
Biophytis SA BPTS
Geschäftsbericht 2023
hinzugefügt 27.12.2025
Biophytis SA Gesamtverbindlichkeiten 2011-2026 | BPTS
Gesamtverbindlichkeiten Jährlich Biophytis SA
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 20.4 M | 25.2 M | 14.9 M | 4.76 M | 3.87 M | 1.85 M | 1.52 M | 1.04 M | 1.08 M | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 25.2 M | 1.04 M | 8.28 M |
Gesamtverbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
395 M | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
5.38 M | - | 4.01 % | $ 150 M | ||
|
MorphoSys AG
MOR
|
1.98 B | - | 2.43 % | $ 254 M | ||
|
Adagene
ADAG
|
38.7 M | $ 2.75 | -5.5 % | $ 155 M | ||
|
ARCA biopharma
ABIO
|
13.8 M | - | 1052.0 % | $ 415 M | ||
|
Albireo Pharma
ALBO
|
126 M | - | -0.23 % | $ 916 M | ||
|
ANI Pharmaceuticals
ANIP
|
855 M | $ 81.6 | -0.49 % | $ 1.58 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.45 B | - | - | $ 40.3 B | ||
|
Amgen
AMGN
|
50 B | $ 342.65 | -0.08 % | $ 184 B | ||
|
Aeglea BioTherapeutics
AGLE
|
90.7 M | - | - | $ 1.01 B | ||
|
Midatech Pharma plc
MTP
|
6.46 M | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
8.16 M | - | -1.52 % | $ 24.7 M | ||
|
Aytu BioScience
AYTU
|
93.3 M | $ 2.63 | 1.74 % | $ 16.5 M | ||
|
Alterity Therapeutics Limited
ATHE
|
5.89 M | $ 3.17 | -2.76 % | $ 7.63 B | ||
|
Akero Therapeutics
AKRO
|
75.8 M | - | - | $ 3.67 B | ||
|
Allena Pharmaceuticals
ALNA
|
15.9 M | - | 3.16 % | $ 1.9 M | ||
|
AVROBIO
AVRO
|
6.35 M | - | 1083.1 % | $ 745 M | ||
|
Aptose Biosciences
APTO
|
14.7 M | - | -45.71 % | $ 1.2 M | ||
|
Aravive
ARAV
|
51.5 M | - | -13.39 % | $ 1.45 M | ||
|
Biogen
BIIB
|
11.3 B | $ 178.24 | 1.2 % | $ 26 B | ||
|
Brickell Biotech
BBI
|
6.5 M | - | -5.38 % | $ 6.06 M | ||
|
Applied Molecular Transport
AMTI
|
46.6 M | - | - | $ 10.1 M | ||
|
Beam Therapeutics
BEAM
|
370 M | $ 27.94 | -4.61 % | $ 2.3 B | ||
|
Институт стволовых клеток человека
ISKJ
|
1.1 B | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
1.29 B | $ 225.36 | 0.63 % | $ 5 B | ||
|
Athira Pharma
ATHA
|
13.9 M | - | - | $ 269 M | ||
|
Atreca
BCEL
|
76.6 M | - | -11.76 % | $ 5.79 M | ||
|
BioNTech SE
BNTX
|
3.12 B | $ 114.18 | -2.22 % | $ 27.2 B | ||
|
Burford Capital Limited
BUR
|
1.45 B | $ 9.67 | 0.16 % | $ 1.52 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
106 M | $ 70.74 | 2.34 % | $ 9.46 B | ||
|
CASI Pharmaceuticals
CASI
|
30.3 M | $ 0.99 | -0.01 % | $ 135 M | ||
|
Aeterna Zentaris
AEZS
|
21.9 M | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
6.61 M | - | -10.17 % | $ 12.2 K | ||
|
Catalyst Biosciences
CBIO
|
38.1 M | $ 9.63 | -5.08 % | $ 634 M | ||
|
Akouos
AKUS
|
45.1 M | - | 0.23 % | $ 488 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
3.77 M | - | -9.72 % | $ 5.89 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
243 M | - | -15.15 % | $ 60.3 M | ||
|
Berkeley Lights
BLI
|
84 M | - | -7.31 % | $ 87 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
3.45 M | $ 4.05 | -1.22 % | $ 8.81 B | ||
|
Amneal Pharmaceuticals
AMRX
|
3.32 B | $ 13.65 | -3.3 % | $ 4.22 B | ||
|
AIkido Pharma
AIKI
|
7.27 M | - | 1.93 % | $ 17.4 M | ||
|
Bellerophon Therapeutics
BLPH
|
5.4 M | - | -74.18 % | $ 955 K | ||
|
Cerus Corporation
CERS
|
144 M | $ 2.32 | -0.22 % | $ 428 M | ||
|
CureVac N.V.
CVAC
|
470 M | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
28.4 M | - | 2.71 % | $ 14 M | ||
|
Alpine Immune Sciences
ALPN
|
107 M | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
5.24 M | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.38 M | - | -11.43 % | $ 502 K | ||
|
Baudax Bio
BXRX
|
34.3 M | - | 0.59 % | $ 63 K |